Skip to main content

Advertisement

Open Peer Review Reports for: Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Apr 2018 Submitted Original manuscript
10 May 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 2
10 May 2018 Submitted Manuscript version 2
21 Jun 2018 Reviewed Reviewer Report - Elba Susana Vazquez
9 Jul 2018 Reviewed Reviewer Report - Yasuyoshi Miyata
10 Jul 2018 Reviewed Reviewer Report - Cristina Rodríguez-Padilla
13 Jul 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 3
13 Jul 2018 Submitted Manuscript version 3
16 Jul 2018 Reviewed Reviewer Report - Elba Susana Vazquez
31 Jul 2018 Reviewed Reviewer Report - Yasuyoshi Miyata
18 Aug 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 4
18 Aug 2018 Submitted Manuscript version 4
1 Oct 2018 Reviewed Reviewer Report - Elba Susana Vazquez
3 Oct 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 5
3 Oct 2018 Submitted Manuscript version 5
4 Oct 2018 Reviewed Reviewer Report - Elba Susana Vazquez
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
12 Oct 2018 Editorially accepted
26 Oct 2018 Article published 10.1186/s12885-018-4946-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement